Avoiding FAA Fines Amidst Increasing Scrutiny and Changing Regulations
A changing regulatory landscape and increased scrutiny is an unavoidable reality within the pharmaceutical and biotech industries. A constant reanalysis of regulations is crucial for all manufacturers. Michael Burdick, Special Agent, Security and Hazardous Materials for the FAA, and Amber Scorah from Pharma IQ, discuss common errors that end up in violations and fines, as well as current enforcement efforts being made by the FAA to ensure compliance.
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.